Publications by authors named "Giuseppe Capri"

Claim this Profile
A
A multidisciplinary approach for patients with metastatic breast cancer: a mixed method study.
Viviana Fusetti, Cinzia Brunelli, Sara Alfieri, Giuseppe Capri, Giulia Bianchi

Support Care Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axillary surgery versus no-axillary staging in T1N0 breast cancer: 20-year follow-up of the INT 09/98 randomized clinical trial.
Roberto Agresti, Marco Sandri, Giuseppe Capri, Giulia Bianchi, Tiziana Triulzi

Br J Surg· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early downmodulation of tumor glycolysis predicts response to fasting-mimicking diet in triple-negative breast cancer patients.
Francesca Ligorio, Andrea Vingiani, Tommaso Torelli, Caterina Sposetti, Lorenzo Drufuca, Giuseppe Capri

Cell Metab· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-week external beam partial breast irradiation: survival and toxicity outcomes.
Riccardo Ray Colciago, Eliana La Rocca, Carlotta Giandini, Alicia Rejas Mateo, Nice Bedini, Giuseppe Capri

J Cancer Res Clin Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing Different Multidisciplinary Team Models Implemented Within One Comprehensive Cancer Center.
Sara Alfieri, Cinzia Brunelli, Claudia Borreani, Giuseppe Capri, Martina Angi

J Multidiscip Healthc· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of First-line Carboplatin-paclitaxel and Carboplatin-gemcitabine in Patients With Advanced Triple-negative Breast Cancer: A Monocentric, Retrospective Comparison.
Riccardo Lobefaro, Luigi Mariani, Giorgia Peverelli, Francesca Ligorio, Giovanni Fucà, Giuseppe Capri

Clin Breast Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pan-immune-inflammation value is associated with clinical outcomes in patients with advanced TNBC treated with first-line, platinum-based chemotherapy: an institutional retrospective analysis.
Leonardo Provenzano, Riccardo Lobefaro, Francesca Ligorio, Emma Zattarin, Luca Zambelli, Giuseppe Capri

Ther Adv Med Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sentinel Node Biopsy Alone or With Axillary Dissection in Breast Cancer Patients After Primary Chemotherapy: Long-Term Results of a Prospective Interventional Study.
Gabriele Martelli, Francesco Barretta, Rosalba Miceli, Secondo Folli, Ilaria Maugeri, Giuseppe Capri

Ann Surg· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Qualitative Study on the Needs of Women with Metastatic Breast Cancer.
Sara Alfieri, Cinzia Brunelli, Giuseppe Capri, Augusto Caraceni, Giulia V Bianchi

J Cancer Educ· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin.
Emma Zattarin, Federico Nichetti, Francesca Ligorio, Laura Mazzeo, Riccardo Lobefaro, Giuseppe Capri

Front Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer.
Claudio Vernieri, Giovanni Fucà, Francesca Ligorio, Veronica Huber, Andrea Vingiani, Giuseppe Capri

Cancer Discov· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged benefit from palbociclib plus letrozole in heavily pretreated advanced male breast cancer: case report.
Emma Zattarin, Francesca Ligorio, Federico Nichetti, Giulia Bianchi, Giuseppe Capri

Tumori· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncological safety of selective axillary dissection after axillary reverse mapping in node-positive breast cancer.
Massimiliano Gennaro, Chiara Listorti, Luigi Mariani, Marco Maccauro, Giulia Bianchi, Giuseppe Capri

Eur J Surg Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Pan-Immune-Inflammation-Value Predicts the Survival of Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Breast Cancer Treated with First-Line Taxane-Trastuzumab-Pertuzumab.
Francesca Ligorio, Giovanni Fucà, Emma Zattarin, Riccardo Lobefaro, Luca Zambelli, Giuseppe Capri

Cancers (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients.
Francesca Ligorio, Luca Zambelli, Achille Bottiglieri, Lorenzo Castagnoli, Emma Zattarin, Giuseppe Capri

Ther Adv Med Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aromatase Inhibitors in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer: Profiles of Psychological Symptoms and Quality of Life in Different Patient Clusters.
Claudia Borreani, Sara Alfieri, Gabriele Infante, Rosalba Miceli, Paola Mariani, Giuseppe Capri

Oncology· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor activity and efficacy of shorter longer duration of anthracycline-taxane neoadjuvant chemotherapy in stage II-III HER2-negative breast cancer: a 10-year, retrospective analysis.
Riccardo Lobefaro, Emma Zattarin, Federico Nichetti, Michele Prisciandaro, Francesca Ligorio, Giuseppe Capri

Ther Adv Med Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors influencing adherence to adjuvant endocrine therapy in breast cancer-treated women: using real-world data to inform a switch from acute to chronic disease management.
Marianna Cavazza, Helen Banks, Michele Ercolanoni, Gjiliola Cukaj, Giulia Bianchi, Giuseppe Capri

Breast Cancer Res Treat· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everolimus versus alpelisib in advanced hormone receptor-positive HER2-negative breast cancer: targeting different nodes of the PI3K/AKT/mTORC1 pathway with different clinical implications.
Claudio Vernieri, Francesca Corti, Federico Nichetti, Francesca Ligorio, Sara Manglaviti, Giuseppe Capri

Breast Cancer Res· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Capecitabine-Vinorelbine is Associated with Longer Overall Survival When Compared to Single-Agent Capecitabine in Patients with Hormone Receptor-Positive Advanced Breast Cancer.
Claudio Vernieri, Michele Prisciandaro, Federico Nichetti, Riccardo Lobefaro, Giorgia Peverelli, Giuseppe Capri

Cancers (Basel)· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives.
Claudio Vernieri, Monica Milano, Marta Brambilla, Alessia Mennitto, Claudia Maggi, Giuseppe Capri

Crit Rev Oncol Hematol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer: A Retrospective Comparison of Efficacy and Safety Profiles.
Claudio Vernieri, Michele Prisciandaro, Monica Milano, Maria Silvia Cona, Claudia Maggi, Giuseppe Capri

Clin Breast Cancer· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single Institution trial of anthracycline- and taxane-based chemotherapy for operable breast cancer: The ASTER study.
Gabriella Mariani, Giulia Galli, Stefano Cavalieri, Pinuccia Valagussa, Giulia Valeria Bianchi, Giuseppe Capri

Breast J· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer.
Claudio Vernieri, Alessia Mennitto, Michele Prisciandaro, Veronica Huber, Monica Milano, Giuseppe Capri

Sci Rep· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor activity and safety profile of weekly carboplatin plus paclitaxel in metastatic breast cancer: a ten-year, monocentric, retrospective study.
Claudio Vernieri, Monica Milano, Alessia Mennitto, Claudia Maggi, Benvenuto Ferrari, Giuseppe Capri

Breast Cancer Res Treat· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis